pubmed-article:19322019 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0010495 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0027540 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0151692 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C1176020 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C1522538 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C0343136 | lld:lifeskim |
pubmed-article:19322019 | lifeskim:mentions | umls-concept:C1407029 | lld:lifeskim |
pubmed-article:19322019 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:19322019 | pubmed:dateCreated | 2009-3-26 | lld:pubmed |
pubmed-article:19322019 | pubmed:abstractText | Innovative treatment strategies in urologic oncology confront the treating physician with a new spectrum of adverse events. With growing understanding of underlying pathomechanisms, we need to identify contraindications against the use of certain antiproliferative drugs. The management of toxicities involves a multidisciplinary approach and thus, the exchange of experience across medical specialties is mandatory. We report a case of fulminant toxic dermatolysis, tissue necrosis and impaired wound healing resulting in the amputation of one forefoot after 6 days of treatment with sunitinib. | lld:pubmed |
pubmed-article:19322019 | pubmed:language | eng | lld:pubmed |
pubmed-article:19322019 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19322019 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19322019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19322019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19322019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19322019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19322019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19322019 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19322019 | pubmed:issn | 1423-0399 | lld:pubmed |
pubmed-article:19322019 | pubmed:author | pubmed-author:SchillingDD | lld:pubmed |
pubmed-article:19322019 | pubmed:author | pubmed-author:StenzlAA | lld:pubmed |
pubmed-article:19322019 | pubmed:author | pubmed-author:WickiGG | lld:pubmed |
pubmed-article:19322019 | pubmed:author | pubmed-author:FeyerabendSS | lld:pubmed |
pubmed-article:19322019 | pubmed:copyrightInfo | Copyright 2009 S. Karger AG, Basel. | lld:pubmed |
pubmed-article:19322019 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19322019 | pubmed:volume | 82 | lld:pubmed |
pubmed-article:19322019 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19322019 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19322019 | pubmed:pagination | 246-8 | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:meshHeading | pubmed-meshheading:19322019... | lld:pubmed |
pubmed-article:19322019 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19322019 | pubmed:articleTitle | Toxic dermatolysis, tissue necrosis and impaired wound healing due to sunitinib treatment leading to forefoot amputation. | lld:pubmed |
pubmed-article:19322019 | pubmed:affiliation | Department of Urology, University of Tubingen, Tubingen, Germany. | lld:pubmed |
pubmed-article:19322019 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19322019 | pubmed:publicationType | Case Reports | lld:pubmed |